Page 218 - Read Online
P. 218

REFERENCES                                            pathogenesis in WHIM syndrome. Cell Host Microbe 2010;8:523-33.
                                                              19.  Lazarczyk M, Cassonnet P, Pons C, Jacob Y, Favre M. The EVER
           1.   Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah   proteins as a natural barrier against papillomaviruses: a new insight
               KV, Snijders PJ, Meijer CJ; International Agency for Research on   into the pathogenesis of human papillomavirus infections. Microbiol
               Cancer Multicenter  Cervical  Cancer Study Group. Epidemiologic   Mol Biol Rev 2009;73:348-70.
               classification of human papillomavirus types associated with cervical   20.  Gulino  AV.  WHIM syndrome: a genetic  disorder of leukocyte
               cancer. N Engl J Med 2003;348:518-27.             trafficking. Curr Opin Allergy Clin Immunol 2003;3:443-50.
           2.   Schiffman M, Clifford G, Buonaguro FM.Classification of weakly   21.  Ortak  T, Uysal  AC,  Alagoz MS, Orbay H, Sensoz O.
               carcinogenic human papillomavirus types: addressing the limits of   Epidermodysplasia verruciformis: an unusual presentation. Dermatol
               epidemiology at the borderline. Infect Agent Cancer 2009;4:8.  Surg 2006; 32:302-6.
           3.   Hafkamp HC, Manni JJ, Speel EJ. Role of human papillomavirus in   22.  Woodman CB, Collins SI, Young LS. The natural history of cervical
               the development of head and neck squamous cell carcinomas. Acta   HPV infection: unresolved issues. Nat Rev Cancer 2007;7:11-22.
               Otolaryngol 2004;124:520-6.                    23.  Howard JD, Chung CH. Biology of human papillomavirus-related
           4.   Devaraj K, Gillison ML, Wu TC. Development of HPV vaccines for   oropharyngeal cancer. Semin Radiat Oncol 2012;22:187-93.
               HPV-associated head and neck squamous cell carcinoma. Crit Rev   24.  Beutner KR, Tyring S. Human papillomaviruses and human disease.
               Oral Biol Med 2003;14:345-62.                     Am J Med 1997;5: 9-15.
           5.   Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H,   25.  Kjaer SK,  Chackerian B, van den Brule  AJ,  Svare EI, Paull G,
               de  Villiers  EM.Classification  of  papillomaviruses  (PVs)  based  on   Walbomers  JM, Schiller  JT, Bock  JE, Sherman  ME, Lowy DR,
               189 PV types and proposal of taxonomic amendments.  Virology   Meijer CL. High-risk human papillomavirus is sexually transmitted:
               2010;401:70-9.                                    evidence from a follow-up study of virgins starting sexual activity
           6.   Doorbar J. Molecular biology of human papillomavirus infection and   (intercourse). Cancer Epidemiol Biomarkers Prev 2001;10:101-6.
               cervical cancer. Clin Sci (Lond) 2006;110:525-41.  26.  Castellsagué X, Ghaffari A, Daniel RW, Bosch FX, Muñoz N, Shah
           7.   Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S,   KV. Prevalence of penile human papillomavirus DNA in husbands
               Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. Epidemiology and   of women with and without cervical neoplasia: a study in Spain and
               natural history of human papillomavirus infections and type-specific   Colombia. J Infect Dis 1997;176:353-61.
               implications in cervical neoplasia. Vaccine 2008;26 Suppl 10:K1-16.  27.  Bosch FX, Castellsagué X, Muñoz N, de Sanjosé S, Ghaffari AM,
           8.   Ekström J, Bzhalava D, Svenback D, Forslund O, Dillner J. High   González LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergara A,
               throughput sequencing reveals diversity of Human Papillomaviruses   Ascunce N, Guerrero E, Shah KV. Male sexual behavior and human
               in cutaneous lesions. Int J Cancer 2011;129:2643-50.  papillomavirus DNA: key risk factors for cervical cancer in Spain. J
           9.   de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H.   Natl Cancer Inst 1996;88:1060-7.
               Classification of papillomaviruses. Virology 2004;324:17-27.  28.  Cason J. Perinatal  acquisition  of cervical  cancer-associated
           10.  Doorbar J, Quint  W, Banks L, Bravo IG, Stoler M, Broker  TR,   papillomaviruses. Br J Obstet Gynaecol 1996;103:853-8.
               Stanley MA. The biology and life-cycle of human papillomaviruses.   29.  Favre M, Majewski S, De Jesus N, Malejczyk M, Orth G, Jablonska S.
               Vaccine 2012;30 Suppl 5:F55-70.                   A possible vertical transmission of human papillomavirus genotypes
           11.  zur Hausen H. Human papillomaviruses in the  pathogenesis  of   associated with epidermodysplasia verruciformis. J Invest Dermatol
               anogenital cancer. Virology 1991;184:9-13.        1998;111:333-6.
           12.  Biedermann  K, Dandachi  N, Trattner  M, Vogl  G, Doppelmayr  H,   30.  Bosch FX, YL Qiao, X Castellsagué. The epidemiology of human
               Moré E, Staudach A, Dietze O, Hauser-Kronberger C. Comparison of   papillomavirus infection and its association with cervical cancer. Int
               real-time PCR signal-amplified in situ hybridization and conventional   J Gynecol Obstet 2006;94:S8-21.
               PCR  for  detection  and  quantification  of  human  papillomavirus  in   31.  Stern PL, MH Einstein. From HPV infection to oncogenesis: a brief
               archival cervical cancer tissue. J Clin Microbiol 2004;42:3758-65.  review of the complex immunobiological events. Curr Cancer Ther
           13.  Middleton  K,  Peh  W,  Southern  S,  Griffin  H,  Sotlar  K,  Nakahara   Rev 2010: 110-6.
               T, El-Sherif A, Morris L,  Seth  R, Hibma  M, Jenkins D, Lambert   32.  van der Burg SH, Melief CJ. Melief, Therapeutic vaccination against
               P, Coleman N, Doorbar J. Organization of human papillomavirus   human papilloma virus induced malignancies. Curr Opin Immunol
               productive cycle during neoplastic progression provides a basis for   2011;23:252-7.
               selection of diagnostic markers. J Virol 2003;77:10186-201.  33.  Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation.
           14.  Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F;   Cell 2011;144:646-74.
               WHO International Agency for Research on Cancer. Carcinogenicity   34.  Laffort C, Le Deist F, Favre M, Caillat-Zucman S, Radford-Weiss I,
               of human papillomaviruses. Lancet Oncol 2005;6:204.  Debré M, Fraitag S, Blanche S, Cavazzana-Calvo M, de Saint Basile
           15.  Nindl  I,  Gottschling  M,  Stockfleth  E.  Human  papillomaviruses   G, de Villartay JP, Giliani S, Orth G, Casanova JL, Bodemer C, Fischer
               and non-melanoma skin cancer:  basic virology and clinical   A. Severe  cutaneous  papillomavirus  disease  after  haemopoietic
               manifestations. Dis Markers 2007;23:247-59.       stem-cell transplantation in patients with severe combined immune
           16.  Gottschling  M,  Göker  M,  Köhler  A,  Lehmann  MD,  Stockfleth   deficiency caused by common gammac cytokine receptor subunit or
               E,  Nindl  I.  Cutaneotropic  human  beta-/gamma-papillomaviruses   JAK-3 deficiency. Lancet 2004;363:2051-4.
               are rarely shared between family  members.  J Invest Dermatol   35.  Gewirtzman A, Bartlett B, Tyring S. Epidermodysplasia verruciformis
               2009;129:2427-34.                                 and human papilloma virus. Curr Opin Infect Dis 2008;21:141-6.
           17.  Bottalico  D, Chen  Z,  Dunne  A, Ostoloza  J, McKinney  S, Sun   36.  Dubina  M, Goldenberg G.  Viral-associated  nonmelanoma  skin
               C, Schlecht NF, Fatahzadeh  M, Herrero R, Schiffman M,   cancers: a review. Am J Dermatopathol 2009;31:561-73.
               Burk RD.  The  oral  cavity  contains  abundant  known and  novel   37.  Weissenborn S, Neale RE, Waterboer T, Abeni D, Bavinck JN, Green
               human papillomaviruses  from the Betapapillomavirus  and   AC, Harwood CA, Euvrard S, Feltkamp MC, de Koning MN, Naldi
               Gammapapillomavirus genera. J Infect Dis 2011;204:787-92.  L, Quint WG, Tessari G, Proby CM, Wieland U, Pfister H; EPI-HPV-
           18.  Chow KY1, Brotin É, Ben Khalifa  Y, Carthagena  L,  Teissier   UV-CA group. Beta-papillomavirus DNA loads in hair follicles of
               S, Danckaert  A, Galzi  JL,  Arenzana-Seisdedos F,  Thierry F,   immunocompetent  people  and organ transplant  recipients.  Med
               Bachelerie F. A pivotal role for CXCL12 signaling in HPV-mediated   Microbiol Immunol 2012;201:117-25.
               transformation  of keratinocytes:  clues to understanding  HPV-  38.  Kanodia S, Fahey LM, Kast  WM. Mechanisms used by human

           208
                                                                                                                         Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ June 15, 2016 ¦
   213   214   215   216   217   218   219   220   221   222   223